Delex Healthcare Group, Inc. — Form D

Delex Healthcare Group, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-31. The offering totals $20.0M. Industry: Pharmaceuticals.

Offering

Filed: 2022-03-31
Form: D
Accession: 0001909093-22-000003
Industry: Pharmaceuticals
Exemptions: 06c
Total offering: $20.0M
Remaining: $20.0M
Minimum investment: $1K
Security types: equity
Revenue range: $1 - $1,000,000
SEC file number: 021-439782

Issuer

Name: Delex Healthcare Group, Inc.
CIK: 0001909093
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 800 THIRD AVENUE SUITE A #1359, NEW YORK, NY, 10022
Phone: 775 391 3237

Officers, directors & promoters (10)

Name	Role	Location
Allery Bambao Flores	Director	Quezon City, Metro Manila, R6
Ana Lyn Pascual Matienzo	Director	Pasig City, Metro Manila, R6
Ma. Lourdes Elvira Primavera Monasterio	Director	Quezon City, Metro Manila, R6
Noel Lagare Omandam	Director	Quezon City, Metro Manila, R6
Allery Bambao Flores	Executive Officer	Quezon City, Metro Manila, R6
Ana Lyn Pascual Matienzo	Executive Officer	Pasig City, Metro Manila, R6
Ma. Lourdes Elvira Primavera Monasterio	Executive Officer	Quezon City, Metro Manila, R6
Noel Lagare Omandam	Executive Officer	Quezon City, Metro Manila, R6
J. de Ruyter Coching Oroceo	Director	Quezon City, Metro Manila, R6
J. de Ruyter Coching Oroceo	Executive Officer	Quezon City, Metro Manila, R6

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2023-04-14	D	—	—
2023-04-14	D	—	—
2022-03-29	D	$20.0M	—

More